↓ Skip to main content

When Should Iatrogenic Polypharmacy Be Considered a Disease?

Overview of attention for article published in The AMA Journal of Ethic, December 2018
Altmetric Badge

Mentioned by

twitter
66 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
When Should Iatrogenic Polypharmacy Be Considered a Disease?
Published in
The AMA Journal of Ethic, December 2018
DOI 10.1001/amajethics.2018.1133
Pubmed ID
Authors

Christine Wieseler

X Demographics

X Demographics

The data shown below were collected from the profiles of 66 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 22%
Professor > Associate Professor 1 11%
Researcher 1 11%
Student > Master 1 11%
Unknown 4 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 22%
Agricultural and Biological Sciences 1 11%
Neuroscience 1 11%
Medicine and Dentistry 1 11%
Unknown 4 44%